AbbVie · 8 hours ago
Senior Counsel, Transactions
AbbVie is a company dedicated to discovering and delivering innovative medicines and solutions for serious health issues. The Senior Counsel, Transactions, will advise AbbVie’s Business Development and Acquisitions team, draft and negotiate key transaction agreements, and provide legal advice on complex corporate transactions.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Identify and resolve highly complex legal issues and drafting and negotiating highly complex corporate transactions
Have extensive experience with managing M&A and pharmaceutical licensing and collaboration/joint venture transactions
Keep abreast of changes in laws that affect pharmaceutical licensing, and M&A transactions, including antitrust/competition, and other corporate and IP matters
Be capable of regularly negotiating highly individualized and sophisticated agreements independently with third parties on matters of strategic importance that affect a substantial portion of AbbVie’s business or are areas of significant importance to management
Be capable of regularly engaging in due diligence and independently interpreting complex existing agreements and advising on complex situations that may arise related to transactions
Select and direct the work of outside counsel, including defining project objectives and managing projects
Maintain and ensure compliance with applicable corporate and divisional policies and procedures
Analyze and clearly communicate legal advice designed to maximize outcomes for patients and for AbbVie on complex, strategic agreements related to pharmaceutical licenses and collaborations and other strategic alliances
Assess and counsel on antitrust and competition risks and considerations, and competition filings, with respect to transactions in multiple jurisdictions
Provide clear advice to clients, including management, ensuring that advice maximizes the potential of our pipeline
Use good judgment in determining whether and when to elevate issues to senior attorneys and senior management
Assist senior legal staff on matters of significant importance to AbbVie that affect a substantial portion of AbbVie's business
Serve as recognized source, for both management and other attorneys, of innovative ideas in complex areas of law, business, or technology
Provide legal guidance, supervision, and support to paralegals and legal support staff
Qualification
Required
Must possess a J.D. degree
8+ years of relevant transactional and/or industry experience
Must meet the professional licensing requirement of the state in which they practice within a two-year time-period
Advanced negotiating skills, and an ability to independently manage complex transactions
Excellent legal analysis skills and crisp, concise communicator
Honed judgment and ability to identify and quickly address critical issues
Ability to use legal training to maximize business opportunities
Strong sense of urgency and drive for successful business outcome in all activities
Experience in advising on ongoing complex contractual relationships, such as development collaborations
Preferred
Experience with drafting and negotiating complex pharmaceutical licensing and collaboration transactions
Experience in providing legal advice for pharmaceutical research and development
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Long-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-11
2026-01-09
2026-01-09
Company data provided by crunchbase